Riskpilot← Back to searchSign inGet full accessTHE IDENTITY PHARMA AS
ASActiveOrg 920168663Anton Tschudis Vei 44D, 1344 HaslumWholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
81.1%
Financial strength
Net profit 2024
NOK 0
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | — |
| Total assets | NOK 367K | +0% |
| Equity | NOK 298K | +0% |
| Employees | 0 | — |
Legal name
THE IDENTITY PHARMA AS
Org number
920168663
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. desember 2017
Share capital
NOK 31 579
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Salg og distribusjon av helse og naturpreparater og legemidler, samt andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Anton Tschudis Vei 44D, 1344 Haslum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −444 | 93 | 137 | −43 | 0 | 0 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −444 | 93 | 137 | −43 | 0 | 0 | 0 |
| Net financials | 0 | 35 | 3 | −0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | −409 | 97 | 136 | −43 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −409 | 97 | 136 | −43 | 0 | 0 | 0 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 30 | 224 | 316 | 375 | 367 | 367 | 367 | 367 |
| Equity | 17 | 108 | 204 | 341 | 298 | 298 | 298 | 298 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 | 116 | 112 | 34 | 69 | 69 | 69 | 69 |
| Total debt | 13 | 116 | 112 | 34 | 69 | 69 | 69 | 69 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172024
Equity ratio
81.1%
This company
38.2%
Market median
+112% vs market
20172024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-11-16 – 2017-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Identity Europe As | Company | 41.0% | 41.0% | 2022 |
Southmeadow Holding As | Company | 23.0% | 23.0% | 2022 |
Traconet Holding As | Company | 10.0% | 10.0% | 2022 |
Orions Hage As | Company | 9.0% | 9.0% | 2022 |
Dymax Invest As | Company | 7.0% | 7.0% | 2022 |
| Individual | 5.0% | 5.0% | 2022 | |
| Individual | 2.5% | 2.5% | 2022 | |
| Individual | 2.5% | 2.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orions Hage As
THE IDENTITY PHARMA AS Board members of THE IDENTITY PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Dyremyhr | Board of Directors | 0 companies |
| Rune Andre Sydengen | Chairman | 0 companies |